Article Details

Novo Nordisk to present more obesity data in the year's second half - MedWatch

Retrieved on: 2024-08-08 19:04:18

Tags for this article:

Click the tags to see associated articles and topics

Novo Nordisk to present more obesity data in the year's second half - MedWatch. View article details on hiswai:

Excerpt

Among other announcements, anticipated phase III results will be announced for the successor to Wegovy, cagrisema, before the end of the year.

Article found on: medwatch.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo